Inventor · disambiguated record
Hannes Fiepko Koolman
Also filed as: KOOLMAN HANNES · KOOLMAN HANNES FIEPKO
19 granted patents·15 pending applications·20 citations·filing 2009–2025
90Inventor score
Files withBOEHRINGER INGELHEIM INT12BOEHRINGER INGELHEIM VETMEDICA GMBH10ABBVIE DEUTSCHLAND8BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC2HEINRICH TIMO1
Top patents by PatentIndex Score
34 records- 0189US11078182B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 3, 2021·4 cites·35 claims
- 0287US10118926B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 6, 2018·10 cites·6 claims
- 0383US11485727B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as autotaxin (ATX) modulatorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Nov 1, 2022·1 cites·28 claims
- 0481US11560388B2Anthelmintic aza-benzothiophene and aza-benzofuran compoundsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2020·Granted Jan 24, 2023·1 cites·27 claims
- 0575US12312356B2Anthelmintic heterocyclic compoundsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Granted May 27, 2025·0 cites·34 claims
- 0675US9169253B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 27, 2015·1 cites·23 claims
- 0774US2023295112A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0873US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 0971US12503474B2Substituted pyrrolo[1,2-b]pyridazines as anthelminticsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Granted Dec 23, 2025·0 cites·27 claims
- 1071US2023100516A1PyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1170US2022048885A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1269US2025236625A1Anthelmintic heterocyclic compoundsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2025·Application pending·0 cites
- 1367US2023022770A1Novel pyridazinesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1466US8703961B2Thiazole derivatives for the treatment of diseases such as cancerHEINRICH TIMO·Filed 2010·Granted Apr 22, 2014·1 cites·13 claims
- 1565US11964977B2Anthelmintic heterocyclic compoundsBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC·Filed 2021·Granted Apr 23, 2024·0 cites·41 claims
- 1664US12269822B2Anthelminthic heterocyclic compoundsBOEHRINGER INGELHEIM ANIMAL HEALTH USA INC·Filed 2019·Granted Apr 8, 2025·0 cites·17 claims
- 1764US11999742B2Substituted pyrrolo[1,2-b]pyridazines as anthelminticsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2022·Granted Jun 4, 2024·0 cites·31 claims
- 1864US11465982B2PyridazinesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 11, 2022·0 cites·28 claims
- 1964US2019048007A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 2062US12391667B2N-methyl, n-(6-(methoxy)pyridazin-3-yl) amine derivatives as Autotaxin (ATX) modulators for the treatment of inflammatory airway or fibrotic diseasesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Aug 19, 2025·0 cites·3 claims
- 2162US10864201B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Dec 15, 2020·0 cites·55 claims
- 2262US2024300957A1Tetrazole-substituted ethyl-sulfone / sulfoximine-pyridine derivativesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 2362US2024327414A1Cyclopropyl-(hetero)aryl-substituted ethyl- sulfone / sulfoximine-pyridine n-oxide derivativesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 2462US2024336615A1Cyclopropyl-(hetero)aryl-substituted ethyl-sulfoxime-pyridine derivativesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2024·Application pending·0 cites
- 2560US2021059992A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2658US12435083B2Cyclopropyl-(hetero)aryl-substituted ethylsulphonyl-pyridine derivativesBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2022·Granted Oct 7, 2025·0 cites·32 claims
- 2758US9994568B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2015·Granted Jun 12, 2018·0 cites·28 claims
- 2857US2020283439A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 2957US2025243197A1Anthelmintic Heterocyclic CompoundsBOEHRINGER INGELHEIM VETMEDICA GMBH·Filed 2025·Application pending·0 cites
- 3055US2019071443A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3153US12358910B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jul 15, 2025·0 cites·14 claims
- 3252US2011207732A1Azaindole derivativesMERCK PATENT GMBH·Filed 2009·Application pending·0 cites
- 3351US12240828B2Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 3449US2017158693A1Hexahydrodiazepinoquinolines carrying a cyclic radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hannes Fiepko Koolman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →